By Mackenzie Tatananni and George Glover
Stock futures were rising on Tuesday as investors regained their footing following another brutal artificial-intelligence selloff.
These stocks were making moves in premarket trading:
Advanced Micro Devices climbed 12%. The chip maker struck a deal with Meta Platforms to supply 6 gigawatts of computing power over several years. AMD also has agreed to give Meta a performance-based warrant for up to 160 million company shares. Meta Platforms ticked down 0.7%.
Home Depot rose 2.1% after the home-improvement retailer beat analysts' earnings and revenue targets for its fiscal fourth quarter. Home Depot's same-store sales rose by 0.4% over the quarter, beating the 0.4% drop that Wall Street was expecting.
U.S.-listed shares of Novo Nordisk slid 3.1% even as the drugmaker and China's United Biotechnology said that an experimental obesity drug they are jointly developing had helped patients to lose weight. Shares tanked 16% on Monday after Novo said its CagriSema obesity drug had failed to outperform Eli Lilly's Zepbound in a clinical trial.
Hims & Hers Health tumbled 7% after the online health platform beat estimates for fourth-quarter earnings but posted weaker-than-expected revenue. Hims' guidance for the current quarter also underwhelmed. Its outlook for adjusted earnings before interest, taxes, depreciation, and amortization looked "particularly weak," said Citi Research analyst Daniel Grosslight.
International Business Machines inched down 0.2%. Shares plummeted 13% on Monday after AI start-up Anthropic wrote a blog post detailing how its Claude Code tool can modernize the computer programming language used on IBM mainframes. It was the stock's largest one-session percentage decline in more than 25 years, according to Dow Jones Market Data.
BWX Technologies jumped 8.1% after the nuclear technology supplier beat Wall Street's fourth-quarter earnings and revenue targets and issued strong guidance for the current year. Shares were already on a good run, jumping 104% over the past 12 months through Monday's close amid excitement about booming demand for nuclear power.
Constellation Energy added 1.4%. The largest nuclear energy provider in the U.S. posted adjusted earnings and revenue that topped analysts' expectations but held off on providing 2026 guidance, saying it would share its outlook late next month.
Diamondback Energy fell 2.3%. The selloff came after the oil and natural gas company missed Wall Street's fourth-quarter earnings target, taking a hit from soft crude prices.
Keysight Technologies rallied 14% after the electronics test equipment manufacturer beat earnings and revenue estimates for its fiscal first quarter. Keysight is still benefiting from the AI boom, which has driven up data-center demand for its products.
Kratos Defense & Security Solutions declined 3% after the drone maker reported better-than-expected fourth-quarter earnings and issued an outlook that implied sales growth of 20%. The good news may already have been priced in, seeing as the stock has risen 280% over the past year as investors have bet on growth in unmanned military systems.
Vir Biotechnology surged 56% after the small biotechnology company recorded a narrower-than-expected loss for the fourth quarter and said it had signed a licensing agreement to develop its prostate cancer treatment with Japan's Astellas Pharma. Under the terms of the deal, Vir will receive $335 million in upfront and near-term milestone payments.
Whirlpool sank 8.8% after the home appliance company announced public offerings of common stock and depositary shares. Whirlpool will use the money raised from the offerings to repay some of its debt and fund investments in automation.
Write to Mackenzie Tatananni at mackenzie.tatananni@barrons.com and George Glover at george.glover@dowjones.com
This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 24, 2026 07:44 ET (12:44 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments